# US 8,277,440 B2 · Implantable device for controlled, extended delivery of parathyroid hormone

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,277,440 B2
- Document ID: US8277440B2
- Status: Granted
- Kind: B2
- Application number: 12/358,850
- Filed: 2009-01-23
- Published: 2009-06-25
- Granted: 2012-10-02
- Earliest claimed: 2002-09-04
- Assignees: MicroCHIPS, Inc.
- Inventors: Dennis Ausiello; John T. Santini, Jr.; Stephen J. Herman; James H. Prescott; Scott A. Uhland; John M. Maloney; Benjamin F. Polito
- Web page: https://patentgrep.com/patent/US8277440B2

## CPC

- A61K 9/0024: {Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue (compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L)}
- A61K 9/0009: {involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis}
- A61K 9/0097: {Medicinal compositions released by microdevices, e.g. microelectromechanical systems [MEMS], microdevices comprising chips or microdevices on silicon}
- A61K 38/29: Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
- A61K 9/0036: {Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Method and devices are provided for extended and controlled delivery of parathyroid hormone to a patient. The method includes implanting a medical device into the patient, the medical device comprising a substrate, a plurality of reservoirs in the substrate, a release system contained in each of the reservoirs, wherein the release system comprises parathyroid hormone; and controllably releasing a pharmaceutically effective amount of the parathyroid hormone from the reservoirs. The parathyroid hormone can be released intermittently, such as once daily over an extended period (e.g., two months, ten months, or more.). The device can further include reservoirs containing a bone resorption inhibitor or other drug for release. The devices are useful in delivering PTH for the treatment and prevention of bone loss, such as associated with osteoporosis.

## Claims

### Claim 1

An implantable device for controlled delivery of parathyroid hormone to a patient in need thereof comprising:
a substrate having a plurality of discrete reservoirs;
a quantity of parathyroid hormone contained in each of the reservoirs;
a plurality of reservoir caps separating said quantity of parathyroid hormone from an environment outside of the reservoirs, and preventing the parathyroid hormone from being released from the implantable device; and
an electrical input lead and an output lead, which leads are continuous with, or connected by an intermetallic junction to, each of the reservoir caps and configured to pass an electric current from a power source through said each reservoir cap and thereby cause the reservoir cap to rupture by electrothermal ablation and permit the parathyroid hormone to be released from the implantable device,
wherein each of said reservoir caps comprises a multi-layer metal structure.

### Claim 2 (depends on 1)

The device of claim 1, wherein the multi-layer structure comprises platinum and titanium.

### Claim 3 (depends on 1)

The device of claim 1, wherein the parathyroid hormone in a dried or lyophilized form.

### Claim 4 (depends on 1)

The device of claim 1, which is adapted to release a pharmaceutically effective amount of the parathyroid hormone from the reservoirs in daily intermittent doses of between about 10 and 300 μg.

### Claim 5 (depends on 1)

The device of claim 1, which is adapted to release the parathyroid hormone once daily over a period of at least six months.

### Claim 6 (depends on 1)

The device of claim 1, wherein the parathyroid hormone is recombinantly synthesized.

### Claim 7 (depends on 1)

The device of claim 1, wherein the parathyroid hormone is a fragment of the complete human hormone that promotes bone growth responsible for bone growth promotion or an analog thereof in which the amino acid sequence is modified yet retains its bone growth promotion property.

### Claim 8 (depends on 1)

The device of claim 1, wherein the parathyroid hormone consists essentially of hPTH 1-34, hPTH 1-38, or hPTH 1-28.
